These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541 [TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations. Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307 [TBL] [Abstract][Full Text] [Related]
7. Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria. Emeraud C; Escaut L; Boucly A; Fortineau N; Bonnin RA; Naas T; Dortet L Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858212 [TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study. Wei J; Zou C; Wang D; Huang A; Niu S J Glob Antimicrob Resist; 2020 Sep; 22():448-451. PubMed ID: 32387260 [TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018). Piérard D; Stone GG BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. Wise MG; Karlowsky JA; Mohamed N; Kamat S; Sahm DF Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1135-1143. PubMed ID: 37526796 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013. Biedenbach DJ; Kazmierczak K; Bouchillon SK; Sahm DF; Bradford PA Antimicrob Agents Chemother; 2015 Jul; 59(7):4239-48. PubMed ID: 25963984 [TBL] [Abstract][Full Text] [Related]
13. Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam. Kazmierczak KM; Biedenbach DJ; Hackel M; Rabine S; de Jonge BL; Bouchillon SK; Sahm DF; Bradford PA Antimicrob Agents Chemother; 2016 Aug; 60(8):4490-500. PubMed ID: 27161636 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016. Sader HS; Castanheira M; Shortridge D; Mendes RE; Flamm RK Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827415 [TBL] [Abstract][Full Text] [Related]
16. Assessment of broth disk elution method for aztreonam in combination with ceftazidime/avibactam against Song P; Xu J; Jiang L; Zhang Q; Liu C Microbiol Spectr; 2024 Oct; 12(10):e0095324. PubMed ID: 39225487 [TBL] [Abstract][Full Text] [Related]
17. In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae. Niu S; Wei J; Zou C; Chavda KD; Lv J; Zhang H; Du H; Tang YW; Pitout JDD; Bonomo RA; Kreiswirth BN; Chen L J Antimicrob Chemother; 2020 Mar; 75(3):559-565. PubMed ID: 31722380 [TBL] [Abstract][Full Text] [Related]
18. Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers. Crandon JL; Nicolau DP Antimicrob Agents Chemother; 2013 Jul; 57(7):3299-306. PubMed ID: 23650162 [TBL] [Abstract][Full Text] [Related]
19. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam. Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313 [TBL] [Abstract][Full Text] [Related]
20. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying Castanheira M; Mendes RE; Sader HS Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031200 [No Abstract] [Full Text] [Related] [Next] [New Search]